A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014
A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014
复制标题
DOI：
10.1016/j.ypmed.2016.08.008
复制
发表时间：
2016-11-01
影响因子：
5.1
通讯作者：
Higgins, Stephen T.
中科院分区：
文献类型：
--
作者：
Davis, Danielle R.;Kurti, Allison N.;Higgins, Stephen T.
本报告描述了对5.2年（2009年11月至2014年12月）内用于物质使用障碍（SUD）的代金券和相关基于货币的应急管理（CM）干预措施的系统性文献综述。使用PubMed搜索引擎、专家咨询和出版的参考书目确定报告。为了纳入，报告必须（a）涉及基于货币的CM;（B）出现在同行评审的期刊上;（c）包括实验比较条件;（d）描述原始研究;（e）使用推断统计评估疗效;（f）使用允许将治疗效果归因于CM的研究设计。69份报告符合纳入标准，并被归类为7个研究趋势：（1）将CM扩展到特殊人群，（2）参数研究，（3）将CM扩展到社区诊所，（4）将CM与药物治疗相结合，（5）将技术纳入CM，（6）调查长期结局，（7）使用CM作为研究工具。绝大多数（59/69，86%）研究报告了显著（p < 0.05）治疗期间效应。这些研究中有28项（28/59，47%）包括CM停药后至少一次随访访视，其中8项（8/28，29%）报告了显著（p B 0.05）效应。治疗期间的平均效应量（Cohen's d）为0.62（95% CI：0.54，0.70），治疗后为0.26（95% CI：0.11，0.41）。总体而言，过去5年中基于凭证的CM文献记录了持续增长、高治疗疗效、治疗期间的中到大效应量（减弱但在治疗终止后仍然明显）以及多种SUD、人群和设置的广度，与既往综述的结果一致并扩展了结果。(C)2016由Elsevier Inc.出版
This report describes a systematic literature review of voucher and related monetary-based contingency management (CM) interventions for substance use disorders (SUDs) over 5.2 years (November 2009 through December 2014). Reports were identified using the search engine PubMed, expert consultations, and published bibliographies. For inclusion, reports had to (a) involve monetary-based CM; (b) appear in a peer-reviewed journal; (c) include an experimental comparison condition; (d) describe an original study; (e) assess efficacy using inferential statistics; (f) use a research design allowing treatment effects to be attributed to CM. Sixty-nine reports met inclusion criteria and were categorized into 7 research trends: (1) extending CM to special populations, (2) parametric studies, (3) extending CM to community clinics, (4) combining CM with pharmacotherapies, (5) incorporating technology into CM, (6) investigating longer-term outcomes, (7) using CM as a research tool. The vast majority (59/69, 86%) of studies reported significant (p < 0.05) during-treatment effects. Twenty-eight (28/59, 47%) of those studies included at least one follow-up visit after CM was discontinued, with eight (8/28, 29%) reporting significant (p b 0.05) effects. Average effect size (Cohen's d) during treatment was 0.62 (95% CI: 0.54, 0.70) and post-treatment it was 0.26 (95% CI: 0.11, 0.41). Overall, the literature on voucher-based CM over the past 5 years documents sustained growth, high treatment efficacy, moderate to large effect sizes during treatment that weaken but remain evident following treatment termination, and breadth across a diverse set of SUDs, populations, and settings consistent with and extending results from prior reviews. (C) 2016 Published by Elsevier Inc.